LITERATURE · PEER REVIEWED

The histone methyltransferase ASH1L protects against bone loss by inhibiting osteoclastogenesis

Cell Death & Differentiation · 2024 · Peer reviewed

COMPLETE CITATION

Citation and identifiers

Zhao X, Lin S, Ren H, et al.. “The histone methyltransferase ASH1L protects against bone loss by inhibiting osteoclastogenesis.” Cell Death & Differentiation. 31(5):605–617 · doi:10.1038/s41418-024-01274-w.

PubMed ID
38431690

RESEARCH QUESTION

How does ASH1L regulate osteoclast differentiation and bone resorption in the tested bone-loss systems?

The study identifies an ASH1L-dependent osteoclastogenesis mechanism that motivates bone-focused measurement but does not attribute any individual skeletal finding to ASH1L.

INTERPRETATION BOUNDARY

Read the finding and limit together.

What this study supports

Defines an ASH1L-dependent osteoclast differentiation and bone-resorption mechanism in the tested systems.

What it cannot establish

Biological rationale for bone-focused measurement, not evidence that an individual skeletal finding is ASH1L-mediated.

OPEN THE STUDY